Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury

Cited by (712)

Items 301–400 of 712

1. Dysbiosis-Related Advanced Glycation Endproducts and Trimethylamine N-Oxide in Chronic Kidney Disease
   Kensei Taguchi, Kei Fukami, Bertha C. Elias, Craig R. Brooks · 2021 · Toxins
2. Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis
   Lin Mao, Ruili Yin, Longyan Yang, Dong Zhao · 2022 · Frontiers in Endocrinology
3. Endogenous secretory RAGE increases with improvements in body composition and is associated with markers of adipocyte health
   Edwin R. Miranda, Kelly N. Z. Fuller, Ryan K. Perkins, Cynthia M. Kroeger, John F. Trepanowski, Krista A Varady, Jacob M. Haus · 2018 · Nutrition Metabolism and Cardiovascular Diseases
4. AGE–RAGE Stress and Coronary Artery Disease
   Kailash Prasad · 2021 · International Journal of Angiology
5. [Role of the receptor for advanced glycation end products (RAGE) in inflammation].
   Jesús Mosquera · 2010 · PubMed
6. Soluble receptor for advanced glycation end products (sRAGE) in plasma and synovial fluid is inversely associated with disease severity of knee osteoarthritis
   Maneerat Chayanupatkul, Sittisak Honsawek · 2010 · Clinical Biochemistry
7. Comparison of distinct protein isoforms of the receptor for advanced glycation end-products expressed in murine tissues and cell lines
   Julia V. Gefter, Angel L. Shaufl, Mitchell P. Fink, Russell L. Delude · 2009 · Cell and Tissue Research
8. Low levels of plasma soluble receptor for advanced glycation end products are associated with severe leukoaraiosis in acute stroke patients
   Chiaki Yokota, Kazuo Minematsu, Yasuhiro Tomii, Masaki Naganuma, Atsushi Ito, Hikaru Nagasawa, Takenori Yamaguchi · 2009 · Journal of the Neurological Sciences
9. AGER gene polymorphisms and soluble receptor for advanced glycation end product in patients with idiopathic pulmonary fibrosis
   Kakuhiro Yamaguchi, Hiroshi Iwamoto, Yasushi Horimasu, Shinichiro Ohshimo, Kazunori Fujitaka, Hironobu Hamada, Witold Mazur, Nobuoki Kohno, Noboru Hattori · 2017 · Respirology
10. Alarmin HMGB1 and Soluble RAGE as New Tools to Evaluate the Risk Stratification in Patients With the Antiphospholipid Syndrome
    Valeria Manganelli, Simona Truglia, Antonella Capozzi, Cristiano Alessandri, Gloria Riitano, Francesca Romana Spinelli, Fulvia Ceccarelli, Silvia Mancuso, Tina Garofalo, Agostina Longo et al. · 2019 · Frontiers in Immunology
11. Circulating soluble receptor for advanced glycation end-product levels are decreased in patients with calcific aortic valve stenosis
    Giuseppina Basta, Anca Irina Corciu, Annamaria Vianello, Serena Del Turco, Ilenia Foffa, Teresa Navarra, Dante Chiappino, Sérgio Luis Berti, Annamaria Mazzone · 2010 · Atherosclerosis
12. Serum endogenous secretory RAGE levels are inversely associated with carotid IMT in type 2 diabetic patients
    Naoto Katakami, Munehide Matsuhisa, Hideaki Kaneto, Yoshimitsu Yamasaki · 2006 · Atherosclerosis
13. The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still’s disease
    Der‐Yuan Chen, Yi‐Ming Chen, Chi‐Chen Lin, Chia‐Wei Hsieh, Yen-Ching Wu, Wei‐Ting Hung, Hsin‐Hua Chen, Joung‐Liang Lan · 2015 · BMC Musculoskeletal Disorders
14. Linking Alzheimer’s Disease and Type 2 Diabetes Mellitus via Aberrant Insulin Signaling and Inflammation
    Mohammad Amjad Kamal, Shubha Priyamvada, Arivarasu Natarajan Anbazhagan, Nasimudeen R. Jabir, Shams S. M. Tabrez, Nigel H. Greig · 2014 · CNS & Neurological Disorders - Drug Targets
15. Expression and purification of recombinant human receptor for advanced glycation endproducts in Escherichia coli
    Rosemarie Wilton, Mohammed Yousef, Poonam Saxena, Mercedes J. Szpunar, Fred J. Stevens · 2006 · Protein Expression and Purification
16. RAGE receptor and its soluble isoforms in diabetes mellitus complications
    Mauren Isfer Anghebem Oliveira, Emanuel Maltempi de Souza, Fábio de Oliveira Pedrosa, Rosangela Roginski Rea, Alexessander Couto Alves, Geraldo Picheth, Fabiane Gomes de Moraes Rego · 2013 · Jornal Brasileiro de Patologia e Medicina Laboratorial
17. Effect of insulin on the soluble receptor for advanced glycation end products (RAGE)
    Joanne K.Y. Lam, Y. Wang, Sammy W.M. Shiu, Yu Man Wong, D. J. Betteridge, K. C. B. Tan · 2013 · Diabetic Medicine
18. Role of endogenous secretory RAGE (esRAGE) in defending against plaque formation induced by oxidative stress in type 2 diabetic patients
    Francesco Piarulli, Annunziata Lapolla, Eugenio Ragazzi, Angela Susana, Annalisa Sechi, Laura Nollino, Chiara Cosma, Domenico Fedele, Giovanni Sartore · 2012 · Atherosclerosis
19. Association of the Receptor for Advanced Glycation End Products Gene Polymorphisms and Circulating RAGE Levels with Diabetic Retinopathy in the Chinese Population
    Yang Li, Qunhong Wu, Yuan Li, Xiaohong Fan, Yanhua Hao, Hong Qiang Sun, Yu Cui, Liyuan Han · 2013 · Journal of Diabetes Research
20. Soluble RAGE Plasma Levels in Patients with Coronary Artery Disease and Peripheral Artery Disease
    Colomba Falcone, Sara Bozzinì, Luigina Guasti, Angela D’Angelo, Anna Clizia Capettini, Edoardo Maria Paganini, Rossana Falcone, Roberto Moia, Carmine Gazzaruso, Gabriele Pelissero · 2013 · The Scientific World JOURNAL
21. Diet and Obesity-Induced Methylglyoxal Production and Links to Metabolic Disease
    Carlos Hernandez-Castillo, Sarah C. Shuck · 2021 · Chemical Research in Toxicology
22. RAGE Splicing Variants in Mammals
    Katharina Anna Sterenczak, Ingo J. A. Nolte, Hugo Murua Escobar · 2012 · Methods in molecular biology
23. Differential effect of plasma or erythrocyte AGE-ligands of RAGE on expression of transcripts for receptor isoforms
    Nicolas Grossin, M.-P. Wautier, Julien Picot, D Stern, Jean‐Luc Wautier · 2009 · Diabetes & Metabolism
24. Significance of Measuring S100A12 and sRAGE in the Serum of Sepsis Patients with Postoperative Acute Lung Injury
    Tomohiro Kikkawa, Nobuhiro Sato, Masahiro Kojika, Gaku Takahashi, Kiichi Aoki, Koichi Hoshikawa, Shinji Akitomi, Tatsuyori Shozushima, Kenji Suzuki, Go Wakabayashi et al. · 2010 · Digestive Surgery
25. AGEs, contributors to placental bed vascular changes leading to preeclampsia
    Luís Guedes‐Martins, Liliana Matos, A. Soares, Elisabete Silva, Henrique Almeida · 2013 · Free Radical Research
26. The decrease of soluble RAGE levels in rheumatoid arthritis patients following hormone replacement therapy is associated with increased bone mineral density and diminished bone/cartilage turnover: a randomized controlled trial
    Rille Pullerits, Helena Forsblad‐d’Elia, A Tarkowski, Hans Carlsten · 2009 · Rheumatology
27. Advanced Glycosylation End Products and Nutrition—A Possible Relation with Diabetic Atherosclerosis and How to Prevent It
    Andreas Xanthis, Apostolos Ioannis Hatzitolios, George Koliakos, V. Tatola · 2007 · Journal of Food Science
28. Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategies
    Masayoshi Takeuchi · 2014 · World Journal of Hepatology
29. Umbilical cord blood biomarkers of neurologic injury and the risk of cerebral palsy or infant death
    Maged M. Costantine, Steven J. Weiner, Dwight J. Rouse, Deborah G. Hirtz, Michael Walter Varner, Catherine Y. Spong, Brian M. Mercer, Jay D. Iams, Ronald J. Wapner, Yoram Sorokin et al. · 2011 · International Journal of Developmental Neuroscience
30. Detection of the receptor for advanced glycation endproducts in neuronally-derived exosomes in plasma
    Sierra A. Patterson, Gagan Deep, Tina E. Brinkley · 2018 · Biochemical and Biophysical Research Communications
31. Pregnancy-Associated Plasma Protein A and Soluble Receptor for Advanced Glycation End Products after Kidney Transplantation
    Marta Kalousová, Kateřina Bartošová, Tomáš Zima, Jelena Skibová, Vladimı́r Teplan, Ondřej Viklický · 2007 · Kidney & Blood Pressure Research
32. Association of serum glycated albumin, C-reactive protein and ICAM-1 levels with diffuse coronary artery disease in patients with type 2 diabetes mellitus
    Jin Cao, Lin Lu, Ruiyan Zhang, Qi Zhang, Feng Hua Ding, Qiujing Chen, Wei Feng Shen · 2009 · Clinica Chimica Acta
33. Interaction of Nε(carboxymethyl)lysine- and methylglyoxalmodified albumin with endothelial cells and macrophages
    Mariska Lieuw-a-Fa, Marten A. Engelse, Victor W.M. van Hinsbergh, Casper G. Schalkwijk · 2006 · Thrombosis and Haemostasis
34. Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinoma
    Jun-ichi Takino · 2015 · World Journal of Hepatology
35. Endogenous Secretory Receptor for Advanced Glycation Endproducts Levels Are Correlated With Serum Pentosidine and CML in Patients With Type 1 Diabetes
    Junnosuke Miura, Yasuhiko Yamamoto, M Osawa, Takuo Watanabe, Hideto Yonekura, Yasuko Uchigata, Hiroshi Yamamoto, Yasuhiko Iwamoto · 2006 · Arteriosclerosis Thrombosis and Vascular Biology
36. RAGE receptor: May be a potential inflammatory mediator for SARS-COV-2 infection?
    Mohsen Kerkeni, Jawhar Gharbi · 2020 · Medical Hypotheses
37. Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis
    Sherman S. Leung, Josephine Maree Forbes, Danielle J. Borg · 2016 · Current Diabetes Reports
38. The −374A allele of the receptor for advanced glycation end products (RAGE) gene promoter is a protective factor against cardiovascular lesions in type 2 diabetes mellitus patients
    Geraldo Picheth, Costantino Ortiz Costantini, Fábio O. Pedrosa, Tânia Leme da Rocha Martinez, Emanuel Maltempi de Souza · 2007 · Clinical Chemistry and Laboratory Medicine (CCLM)
39. Crosstalk Between Calcium, Amyloid β and the Receptor for Advanced Glycation Endproducts in Alzheimer's Disease
    Estelle Leclerc, Emmanuel Sturchler, Stefan W. Vetter, Claus W. Heizmann · 2009 · Reviews in the Neurosciences
40. Soluble RAGE blocks scavenger receptor CD36‐mediated uptake of hypochlorite‐modified low‐density lipoprotein
    Gunther Marsche, Bernd Weigle, Wolfgang Sattler, Ernst Malle · 2007 · The FASEB Journal
41. Involvement of Receptor for Advanced Glycation Endproducts in Hypertensive Disorders of Pregnancy
    Juria Akasaka, Katsuhiko Naruse, Toshiyuki Sado, Tomoko Uchiyama, Mai Makino, Akiyo Yamauchi, Hiroyo Ota, Sumiyo Sakuramoto‐Tsuchida, Asako Itaya‐Hironaka, Shin Takasawa et al. · 2019 · International Journal of Molecular Sciences
42. Do Statins have a Role in Reduction/Prevention of Post‐PCI Restenosis?
    Kailash Prasad · 2011 · Cardiovascular Therapeutics
43. Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent?
    Kateřina Kaňková · 2008 · Proceedings of The Nutrition Society
44. Below the radar: advanced glycation end products that detour "around the side". Is HbA1c not an accurate enough predictor of long term progression and glycaemic control in diabetes?
    Josephine Maree Forbes, Georgia Soldatos, Merlin C. Thomas · 2005 · Europe PMC (PubMed Central)
45. Biomarkers of oxidation stress, inflammation, necrosis and apoptosis are associated with hepatitis B-related acute-on-chronic liver failure
    Junjun Cai, Tao Han, Caiyun Nie, Xiaobo Jia, Ying Liu, Zhengyan Zhu, Yingtang Gao · 2015 · Clinics and Research in Hepatology and Gastroenterology
46. Low Levels of sRAGE Are Associated With Increased Risk for Mortality in Renal Transplant Recipients
    Sascha Groß, Rutger M. van Ree, Leendert Harmen Oterdoom, Aiko P. J. de Vries, Willem J. van Son, Paul E. de Jong, Gerjan Navis, Mike W. Zuurman, Angelika Bierhaus, Rijk O. B. Gans et al. · 2007 · Transplantation
47. Decreased levels of soluble receptor for advanced glycation end products in patients with primary Sjögren’s syndrome
    Carol Stewart, Seunghee Cha, Robert M. Caudle, Kathleen M. Berg, Joseph Katz · 2008 · Rheumatology International
48. Association of 2184AG Polymorphism in the RAGE Gene with Diabetic Nephropathy in Chinese Patients with Type 2 Diabetes
    Wei Cai, Jian Li, Jixiong Xu, Ying Liu, Wei Zhang, Jun-Ren Xiao, Lingyan Zhu, Jianying Liu · 2015 · Journal of Diabetes Research
49. Gene Expression of Sirtuin-1 and Endogenous Secretory Receptor for Advanced Glycation End Products in Healthy and Slightly Overweight Subjects after Caloric Restriction and Resveratrol Administration
    Alessandra Roggério, Célia Maria Cássaro Strunz, Ana Paula Pacanaro, Dalila Pinheiro Leal, Júlio Yoshio Takada, Solange Desirée Avakian, Antônio de Pádua Mansur · 2018 · Nutrients
50. Transport of oxytocin to the brain after peripheral administration by membrane‐bound or soluble forms of receptors for advanced glycation end‐products
    Seiichi Munesue, Mingkun Liang, Ai Harashima, Jing Zhong, Kazumi Furuhara, Elizabeta B Boitsova, Черепанов Станислав Михайлович, Maria Gerasimenko, Teruko Yuhi, Yasuhiko Yamamoto et al. · 2021 · Journal of Neuroendocrinology
51. The Role of Advanced Glycation End Products on Dyslipidemia
    Jelena Vekić, Sanja Vujčić, Biljana Bufan, Dragana Bojanin, Khamis Al-Hashmi, Khalid Al‐Rasadi, Anca Pantea Stoian, Aleksandra Zeljković, Manfredi Rizzo · 2023 · Metabolites
52. G allele at RAGE SNP82 is associated with proinflammatory markers in obese subjects
    Oh Yoen Kim, Seog Hyun Jo, Yangsoo Jang, Jey Sook Chae, Ji Young Kim, Yae Jung Hyun, Jong Ho Lee · 2009 · Nutrition Research
53. MK615 decreases RAGE expression and inhibits TAGE-induced proliferation in hepatocellular carcinoma cells
    Yuhki Sakuraoka · 2010 · World Journal of Gastroenterology
54. Increased glycated albumin and decreased esRAGE levels in serum are related to negative coronary artery remodeling in patients with type 2 diabetes: an Intravascular ultrasound study
    Run Du, Ruiyan Zhang, Lin Lu, Ying H. Shen, Li Jin Pu, Zheng Bin Zhu, Qi Zhang, Jian Hu, ZHEN KUN YANG, Feng Hua Ding et al. · 2018 · Cardiovascular Diabetology
55. Soluble Forms of the Receptor for Advanced Glycation Endproducts (RAGE) in Periodontitis
    Laurent Detzen, Bin Cheng, Ching‐Yuan Chen, Panos N. Papapanou, Evanthia Lalla · 2019 · Scientific Reports
56. Neuroprotective Effects of Endogenous Secretory Receptor for Advanced Glycation End-products in Brain Ischemia
    Yu Shimizu, Ai Harashima, Seiichi Munesue, Masahiro Oishi, Tsuyoshi Hattori, Osamu Hori, Yasuko Kitao, Hiroshi Yamamoto, Nontaphat Leerach, Mitsutoshi Nakada et al. · 2020 · Aging and Disease
57. Soluble RAGE: a hot new biomarker for the hot joint?
    Bernhard Moser, Barry Ian Hudson, Ann‐Marie Schmidt · 2005 · Arthritis Research & Therapy
58. Bone metabolism and fracture risk in type 2 diabetes mellitus
    Toru Yamaguchi, Toshitsugu Sugimoto · 2012 · BoneKEy Reports
59. Aquaporin 1 elicits cell motility and coordinates vascular bed formation by downregulating thrombospondin type‐1 domain‐containing 7A in glioblastoma
    Masahiro Oishi, Seiichi Munesue, Ai Harashima, Mitsutoshi Nakada, Yasuhiko Yamamoto, Yasuhiko Hayashi · 2020 · Cancer Medicine
60. Glycation reaction and the role of the receptor for advanced glycation end-products in immunity and social behavior
    Nontaphat Leerach, Ai Harashima, Seiichi Munesue, Kumi Kimura, Yu Oshima, Hisanori Goto, Hiroshi Yamamoto, Haruhiro Higashida, Yasuhiko Yamamoto · 2020 · Glycoconjugate Journal
61. Hypoxia and the Receptor for Advanced Glycation End Products (RAGE) Signaling in Cancer
    Sakshi Taneja, Stefan W. Vetter, Estelle Leclerc · 2021 · International Journal of Molecular Sciences
62. Plasma s RAGE and N ‐(carboxymethyl) lysine in patients with CHF and/or COPD
    Piera Boschetto, Ilaria Campo, Mariarita Stendardo, Enrico Casimirri, Carmine Tinelli, Marina Gorrini, Claudio Ceconi, Alessandro Fucili, A Potena, Alberto A. Papi et al. · 2013 · European Journal of Clinical Investigation
63. Increased glycated albumin and decreased esRAGE concentrations are associated with in-stent restenosis in Chinese diabetic patients
    Lin Lu, Li Jin Pu, Qiujing Chen, Linjie Wang, Wenhui Peng, Xiaoxiang Yan, Qi Zhang, Ruiyan Zhang, Pei Hua Gong, Jian Ping Qiu et al. · 2008 · Clinica Chimica Acta
64. Bone fragility in type 2 diabetes mellitus
    Toru Yamaguchi · 2010 · World Journal of Orthopedics
65. Endogenous Secretory Receptor for Advanced Glycation End-Products and Cardiovascular Disease in End-Stage Renal Disease
    Yoshiki Nishizawà, Hidenori Koyama · 2007 · Journal of Renal Nutrition
66. Can advanced glycation end‐products and their receptors be affected by weight loss? A systematic review
    Juliana F. Tavares, Priscila Vaz de Melo Ribeiro, Olívia Gonçalves Leão Coelho, Laís E. da Silva, Rita de Cássia Gonçalves Alfenas · 2020 · Obesity Reviews
67. The different isoforms of the receptor for advanced glycation end products are modulated by pharmacological agents
    Nicolas Grossin, Éric Boulanger, Marie‐Paule Wautier, Jean‐Luc Wautier · 2010 · Clinical Hemorheology and Microcirculation
68. Soluble RAGE, diabetic nephropathy and genetic variability in theAGERgene
    Kateřina Kaňková, Marta Kalousová, Miluše Hertlová, Darja Krusová, Jindřich Olšovský, Tomáš Zima · 2008 · Archives of Physiology and Biochemistry
69. Downregulation of an Astrocyte-Derived Inflammatory Protein, S100B, Reduces Vascular Inflammatory Responses in Brains Persistently Infected with Borna Disease Virus
    Naohiro Ohtaki, Wataru Kamitani, Yohei Watanabe, Yohei Hayashi, Hideyuki Yanai, Kazuyoshi Ikuta, Keizō Tomonaga · 2007 · Journal of Virology
70. The RAGE Pathway in Skin Pathology Development: A Comprehensive Review of Its Role and Therapeutic Potential
    Marcin Radziszewski, Ryszard Galus, Krzysztof Łuszczyński, Sebastian Winiarski, Dariusz Wąsowski, Jacek Malejczyk, Pawel Krzysztof Wlodarski, Aneta Ścieżyńska · 2024 · International Journal of Molecular Sciences
71. A Soluble Receptor for Advanced Glycation End-Products Inhibits Hypoxia/Reoxygenation-Induced Apoptosis in Rat Cardiomyocytes via the Mitochondrial Pathway
    Caixia Guo, Xiangjun Zeng, Juanjuan Song, Min Zhang, Hongxia Wang, Xiaowei Xu, Fenghe Du, Buxing Chen · 2012 · International Journal of Molecular Sciences
72. Impact of Dietary Advanced Glycation End Products on Female Reproduction: Review of Potential Mechanistic Pathways
    Marco Mouanness, Zaher O Merhi · 2022 · Nutrients
73. Is it all the RAGE ? Defining the role of the receptor for advanced glycation end products in Parkinson's disease
    Juciano Gasparotto, Nauana Somensi, Carolina Saibro Girardi, Reykla Ramon Bittencourt, Laura Martinewski de Oliveira, Laura Piloneto Lima Hoefel, Ingrid Matsubara Scheibel, Daniel Oppermann Peixoto, José Cláudio Fonseca Moreira, Tiago F. Outeiro et al. · 2023 · Journal of Neurochemistry
74. Controlling the receptor for advanced glycation end‐products to conquer diabetic vascular complications
    Yasuhiko Yamamoto, Hiroshi Yamamoto · 2012 · Journal of Diabetes Investigation
75. Advanced glycation end products and C-peptide—modulators in diabetic vasculopathy and atherogenesis
    Daniel Walcher, Nikolaus Marx · 2009 · Seminars in Immunopathology
76. Serum Levels of Receptors for Advanced Glycation End Products in Normal-Weight and Obese Children Born Small and Large for Gestational Age
    Valentina Chiavaroli, Ebe D’Adamo, Cosimo Giannini, Tommaso de Giorgis, Stefania De Marco, Francesco Chiarelli, Angelika Mohn · 2012 · Diabetes Care
77. Advanced glycation end products (AGEs) and its receptors in the pathogenesis of hyperthyroidism
    Gudrun Caspar‐Bell, Indu Dhar, Kailash Prasad · 2016 · Molecular and Cellular Biochemistry
78. Endogenous Secretory Receptor for Advanced Glycation End Products in Non–Small Cell Lung Carcinoma
    Seiichi Kobayashi, Hiroshi Kubo, Takashi Suzuki, Kota Ishizawa, Mitsuhiro Yamada, Mei Tong He, Yasuhiko Yamamoto, Hiroshi Yamamoto, Hironobu Sasano, Hidetada Sasaki et al. · 2006 · American Journal of Respiratory and Critical Care Medicine
79. Altered serum glyceraldehyde-derived advanced glycation end product (AGE) and soluble AGE receptor levels indicate carbonyl stress in patients with schizophrenia
    Mayu Takeda, Tohru Ohnuma, Masayoshi Takeuchi, Narimasa Katsuta, Hitoshi Maeshima, Yuto Takebayashi, Motoyuki Higa, Toru Nakamura, Shohei Nishimon, Takahiro Sannohe et al. · 2015 · Neuroscience Letters
80. JNK and ATF4 as two important platforms for tumor necrosis factor‐α–stimulated shedding of receptor for advanced glycation end products
    Akio Miyoshi, Sachie Koyama, Masayo Sasagawa-Monden, Manabu Kadoya, Kosuke Konishi, Takuhito Shoji, Masaaki Inaba, Yasuhiko Yamamoto, Hidenori Koyama · 2018 · The FASEB Journal
81. Association between Advanced Glycation End Products, Soluble RAGE Receptor, and Endothelium Dysfunction, Evaluated by Circulating Endothelial Cells and Endothelial Progenitor Cells in Patients with Mild and Resistant Hypertension
    Bogna Gryszczyńska, Magdalena Budzyń, Beata Krasińska, Angelika Osińska, Maciej Boruczkowski, Mariusz Kaczmarek, Alicja Bukowska, Maria Iskra, Magdalena Paulina Kasprzak · 2019 · International Journal of Molecular Sciences
82. Soluble receptor for advanced glycation end-products promotes angiogenesis through activation of STAT3 in myocardial ischemia/reperfusion injury
    Xianxian Cao, Bin Li, Xuejie Han, Xiuling Zhang, Mengqiu Dang, Hongxia Wang, Fenghe Du, Xiangjun Zeng, Caixia Guo · 2020 · APOPTOSIS
83. The perplexing role of RAGE in pulmonary fibrosis: causality or casualty?
    Timothy N. Perkins, Tim D. Oury · 2021 · Therapeutic Advances in Respiratory Disease
84. The Remarkable Roles of the Receptor for Advanced Glycation End Products (RAGE) and Its Soluble Isoforms in COVID-19: The Importance of RAGE Pathway in the Lung Injuries
    Mitra Salehi, Shahin Amiri, Dariush Ilghari, Lawahidh Fadhil Ali Hasham, Hossein Piri · 2022 · Indian Journal of Clinical Biochemistry
85. Relationship of Soluble RAGE with Insulin Resistance and Beta Cell Function during Development of Type 2 Diabetes Mellitus
    Subrata Kumar Biswas, Sabreena Mohtarin, Sonchita Rani Mudi, Taznuva Anwar, Laila Anjuman Banu, Sheikh Md. Khorshed Alam, Md Fariduddin, MI Arslan · 2015 · Journal of Diabetes Research
86. The receptor for advanced glycation end products mediates lung endothelial activation by RBCs
    Nilam S. Mangalmurti, Jessica L. Friedman, Liang-Chuan Wang, Donna Beer Stolz, Geetha Muthukumaran, Don L. Siegel, Ann Marie Schmidt, Janet S. Lee, Steven Μ. Albelda · 2012 · American Journal of Physiology-Lung Cellular and Molecular Physiology
87. Glycation in diabetic nephropathy
    Josephine Maree Forbes, Mark Emmanuel Cooper · 2010 · Amino Acids
88. Involvement of TAGE-RAGE System in the Pathogenesis of Diabetic Retinopathy
    Masayoshi Takeuchi, Jun-ichi Takino, Sho‐ichi Yamagishi · 2010 · Journal of Ophthalmology
89. The alarmin functions of high-mobility group box-1 and IL-33 in the pathogenesis of systemic lupus erythematosus
    Shuilian Yu, Chun Kwok Wong, Lai‐Shan Tam · 2013 · Expert Review of Clinical Immunology
90. Association Between Serum Levels of the Soluble Receptor (sRAGE) for Advanced Glycation Endproducts (AGEs) and their Receptor (RAGE) in Peripheral Blood Mononuclear Cells of Children with Type 1 Diabetes Mellitus
    Athina Dettoraki, Andrea Paola Rojas Gil, Bessie Eugenia Spiliotis · 2009 · Journal of Pediatric Endocrinology and Metabolism
91. AGE–RAGE Stress in the Pathophysiology of Pulmonary Hypertension and its Treatment
    Kailash Prasad · 2019 · International Journal of Angiology
92. Expression of Receptor for Advanced Glycation End Products in Sarcoid Granulomas
    Ilaria Campo, Patrizia Morbini, Michele Zorzetto, Carmine Tinelli, Enrico Brunetta, Chiara Villa, Cristina Bombieri, Mariaclara Cuccia, Carlo Agostini, Valeria Bozzi et al. · 2006 · American Journal of Respiratory and Critical Care Medicine
93. Overexpression of Receptor for Advanced Glycation End Products Induces Monocyte Chemoattractant Protein-1 Expression in Rat Vascular Smooth Muscle Cell Line
    Eri Hayakawa, Takanobu Yoshimoto, Naoko Sekizawa, Toru Sugiyama, Yukio Hirata · 2011 · Journal of Atherosclerosis and Thrombosis
94. Tissue-Specific Expression Profiling of Receptor for Advanced Glycation End Products and Its Soluble Forms in Esophageal and Lung Cancer
    Rongrong Jing, Ming Cui, Baolan Sun, Juan Yu, Huimin Wang · 2010 · Genetic Testing and Molecular Biomarkers
95. Calcitriol Treatment Increases Serum Levels of the Soluble Receptor of Advanced Glycation End Products in Hemodialysis Patients with Secondary Hyperparathyroidism
    Ji Yoon Sung, Wookyung Chung, Ae Jin Kim, Hyung Soo Kim, Han Ro, Jae Hyun Chang, Hyun Hee Lee, Ji Yong Jung · 2013 · The Tohoku Journal of Experimental Medicine
96. Is There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer’s Disease?
    Lih‐Fen Lue, Cassandra Andrade, Marwan Noel Sabbagh, Douglas G. Walker · 2012 · International Journal of Alzheimer s Disease
97. Therapeutic Effectiveness of Anti-RAGE Antibody Administration in a Rat Model of Crush Injury
    Hisatake Matsumoto, Naoya Matsumoto, Junya Shimazaki, Junichiro Nakagawa, Yukio Imamura, Kazuma Yamakawa, Tomoki Yamada, Mitsunori Ikeda, Hiroko Hiraike, Hiroshi Ogura et al. · 2017 · Scientific Reports
98. Polymorphisms in the receptor for advanced glycation end-products (RAGE) gene and circulating RAGE levels as a susceptibility factor for non-alcoholic steatohepatitis (NASH)
    Rohini Mehta, Gladys A. Shaw, Peter M. Masschelin, Sean C. Felix, Munkzhul Otgonsuren, Ancha V. Baranova, Zachary D Goodman, Zobair M. Younossi · 2018 · PLoS ONE
99. Endogenous Secretory RAGE as a Novel Biomarker for Metabolic Syndrome and Cardiovascular Diseases
    Hidenori Koyama, Hiroshi Yamamoto, Yoshiki Nishizawà · 2007 · Biomarker Insights
100. Endogenous Secretory RAGE as a Novel Biomarker for Metabolic Syndrome and Cardiovascular Diseases.
     Hidenori Koyama, Hiroshi Yamamoto, Yoshiki Nishizawà · 2007 · PubMed Central